Rousselot, Darling Ingredients’ health brand, has been granted patents in Europe, Japan, and China for Colartix, its unique matrix of collagen peptides and chondroitin sulfate. Specifically designed for joint care, Colartix is now patented under the title Collagen hydrolysate composition for reducing joint pain after exercise.  

“These new patents are a milestone that underscores our commitment and ability to innovate in the collagen industry,” said Jeroen Colpaert, Executive Vice President, Rousselot. “They not only provide exclusive protection to our Colartix customers but also strengthen their product appeal to consumers through association with proven innovation and trust.” 

Backed by scientific research demonstrating its efficacy in alleviating joint discomfort across gender, age, and sport intensity^[1], Colartix has gained strong market traction since its launch in 2022. Widely incorporated into dietary supplements, it supports both active individuals and those experiencing wear and tear due to aging or excess weight. This demand aligns with the joint health supplement market, which hit $4.4 billion in 2024 and is set to grow 2.4% annually through 2029.^[2] 

Colartix is a natural, safe, and easy-to-use ingredient, delivering benefits with just 1 gram of daily intake. Its small daily dosage and ability to blend seamlessly with other ingredients make it ideal for a variety of applications, including capsules, powder supplements, tablets, and shots.  

The European patent, granted by the European Patent Office, is registered under the number EP4465823B1. The Japanese patent, issued by the Japan Patent Office, holds the number JP7690140B2. The Chinese patent, granted by the China National Intellectual Property Administration, is registered under number CN118829360. Patent applications for Colartix are also pending in Brazil and the United States. 

For more information on Colartix and Rousselot’s joint health solutions, visit rousselot.com or colartix.com.

Rousselot makes no representation or warranty, whether expressed or implied, as to the accuracy, reliability, or completeness of the information, nor does it assume any legal liability, whether direct or indirect, for any information. Use of this information shall be at your discretion and risk. Nothing herein relieves you from carrying out your own suitability determinations and tests and from your obligation to comply with all applicable laws and regulations and to observe all third-party rights. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Rousselot

Rousselot, the health brand of Darling Ingredients, is the global leader in gelatin- and collagen-based solutions for the food, health & nutrition, biomedical, and pharmaceutical industries. Working in partnership with our global customer base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers, and contribute to public health. Through our state-of-the-art operations, extensive technical expertise, and sustained scientific research, we help our customers achieve their goals and create world-class products, and we “Reach further together.”

^[1] Newman, C., et al. Development of a Mobile App to Monitor the Effectiveness of a Hydrolyzed Cartilage Matrix Supplement on Joint Discomfort: Real-World Study. JMIR Formative Research. 2023. https://doi.org/10.2196/42967

^[2] Euromonitor – Passport (2024); CAGR Forecasted Growth adapted from Euromonitor